Kutok Jeffery 4
4 · Epizyme, Inc. · Filed Feb 2, 2021
Insider Transaction Report
Form 4
Epizyme, Inc.EPZM
Kutok Jeffery
Chief Scientific Officer
Transactions
- Award
Common Stock
2021-02-01+28,645→ 56,057 total - Award
Stock Option (Right to Buy)
2021-02-01+136,663→ 136,663 totalExercise: $11.02Exp: 2031-01-31→ Common Stock (136,663 underlying)
Footnotes (2)
- [F1]Consists of shares of Common Stock issuable under 28,645 restricted stock units ("RSUs") granted pursuant to the Company's 2013 Stock Incentive Plan. Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest in four equal annual installments over four years from the grant date, with the first installment vesting on February 1, 2022.
- [F2]This option was granted on February 1, 2021 pursuant to the Company's 2013 Stock Incentive Plan with respect to 136,663 shares of Common Stock, with 25% vesting on February 1, 2022 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.